Atara Joins Flood Of Life Science Cos. Tapping Market
Venture capital-backed Atara Biotherapeutics Inc., whose lead product addresses muscle loss, filed Wednesday to raise roughly $74 million in a follow-on offering three months after a disappointing initial public offering, marking...To view the full article, register now.
Already a subscriber? Click here to view full article